Regulation of p53 by the Ubiquitin-conjugating Enzymes UbcH5B/C in Vivo*

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Biological Chemistry

• Publication date

  2004-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1074/JBC.M403362200PMID 15280377
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteasome inhibition with PS-341 (bortezomib) in lung cancer therapy.

  2004cited by this paper
• Regulation of the ubiquitin proteasome pathway in human lens epithelial cells during the cell cycle.

  2004cited by this paper
• Accelerated MDM2 auto‐degradation induced by DNA‐damage kinases is required for p53 activation

  2004cited by this paper
• Regulating the p53 system through ubiquitination

  2004cited by this paper
• The ubiquitin ligase COP1 is a critical negative regulator of p53

  2004cited by this paper
• In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

  2004cited by this paper
• To Be or Not to Be...Ubiquitinated?

  2004cited by this paper
• Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity.

  2004cited by this paper
• The proteasome as a target for cancer therapy.

  2003cited by this paper
• The p53-Mdm2 module and the ubiquitin system.

  2003cited by this paper
• UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.

  2003cited by this paper
• Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.

  2003cited by this paper
• Essential Role of E2-25K/Hip-2 in Mediating Amyloid-β Neurotoxicity

  2003cited by this paper
• A phase 2 study of bortezomib in relapsed, refractory myeloma.

  2003cited by this paper
• DNA Damage-induced MDMX Degradation Is Mediated by MDM2*

  2003cited by this paper
• mdm2 Is Critical for Inhibition of p53 during Lymphopoiesis and the Response to Ionizing Irradiation

  2003cited by this paper
• Supramolecular Complex Formation between Rad6 and Proteins of the p53 Pathway during DNA Damage-Induced Response

  2003cited by this paper
• Essential role of E2-25K/Hip-2 in mediating amyloid-beta neurotoxicity.

  2003cited by this paper
• Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation.

  2003cited by this paper
• Exploiting the p53 pathway for cancer diagnosis and therapy.

  2003cited by this paper
• Posttranslational modification of MDM2.

  2003cited by this paper
• Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2

  2003cited by this paper
• The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a

  2003cited by this paper
• Improving cancer therapy by non-genotoxic activation of p53.

  2003cited by this paper
• Decision making by p53: life, death and cancer

  2003cited by this paper
• CK2-dependent phosphorylation of the E2 ubiquitin conjugating enzyme UBC3B induces its interaction with β-TrCP and enhances β-catenin degradation

  2002cited by this paper
• Control of ubiquitination of proteins in rat tissues by ubiquitin conjugating enzymes and isopeptidases.

  2002cited by this paper
• Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1

  2002cited by this paper
• mdmx is a negative regulator of p53 activity in vivo.

  2002cited by this paper
• A System for Stable Expression of Short Interfering RNAs in Mammalian Cells

  2002cited by this paper
• MdmX Is a RING Finger Ubiquitin Ligase Capable of Synergistically Enhancing Mdm2 Ubiquitination*

  2002cited by this paper
• Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors

  2002cited by this paper
• CK2-dependent phosphorylation of the E2 ubiquitin conjugating enzyme UBC3B induces its interaction with beta-TrCP and enhances beta-catenin degradation.

  2002cited by this paper
• Regulation of the ubiquitin‐conjugating enzyme hHR6A by CDK‐mediated phosphorylation

  2002cited by this paper
• Requirement for HDM2 Activity in the Rapid Degradation of p53 in Neuroblastoma*

  2001cited by this paper
• Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms

  2001cited by this paper
• Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo

  2001cited by this paper
• COP9 signalosome‐specific phosphorylation targets p53 to degradation by the ubiquitin system

  2001cited by this paper
• Mechanisms underlying ubiquitination.

  2001cited by this paper
• Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

  2001cited by this paper
• Regulation and function of the p53 tumor suppressor protein.

  2001cited by this paper
• Human mdm2 Mediates Multiple Mono-ubiquitination of p53 by a Mechanism Requiring Enzyme Isomerization*

  2001cited by this paper
• Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53

  2001cited by this paper
• An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo

  2000cited by this paper
• Induction of ubiquitin-conjugating enzyme by aggregated low density lipoprotein in human macrophages and its implications for atherosclerosis.

  2000cited by this paper
• P53-independent down-regulation of Mdm2 in human cancer cells treated with adriamycin.

  2000cited by this paper
• Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53*

  2000cited by this paper
• The ubiquitin system

  2000cited by this paper
• Proteome analysis reveals ubiquitin-conjugating enzymes to be a new family of interferon-alpha-regulated genes.

  2000cited by this paper
• Cell cycle-regulated proteolysis of mitotic target proteins.

  1999cited by this paper
• Activation of a UBC4-dependent pathway of ubiquitin conjugation during postnatal development of the rat testis.

  1999cited by this paper
• Identification of the Ubiquitin Carrier Proteins, E2s, Involved in Signal-induced Conjugation and Subsequent Degradation of IκBα*

  1999cited by this paper
• The measurement of ubiquitin and ubiquitinated proteins

  1999cited by this paper
• Identification of the Enzyme Required for Activation of the Small Ubiquitin-like Protein SUMO-1*

  1999cited by this paper
• Functions of the MDM2 oncoprotein

  1999cited by this paper
• MDM2 interacts with MDMX through their RING finger domains

  1999cited by this paper
• Comparative study of the p53-mdm2 and p53-MDMX interfaces

  1999cited by this paper
• Transcription Factor E2F-1 Is Upregulated in Response to DNA Damage in a Manner Analogous to That of p53

  1999cited by this paper
• The ubiquitin system.

  1998cited by this paper
• Methods used to study structure and function of the nucleolus.

  1998cited by this paper
• JNK targets p53 ubiquitination and degradation in nonstressed cells.

  1998cited by this paper
• Reconstituting ubiquitination reactions with affinity-purified components and 32P-ubiquitin.

  1998cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• Ubch9 conjugates SUMO but not ubiquitin

  1997cited by this paper
• MDM2--arbiter of p53's destruction.

  1997cited by this paper
• Structure and function of ubiquitin conjugating enzyme E2-25K: the tail is a core-dependent activity element.

  1997cited by this paper
• Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

  1997cited by this paper
• Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo.

  1997cited by this paper
• Activity of Ubiquitin-dependent Pathway in Response to Oxidative Stress

  1997cited by this paper
• Repression of p53-mediated transcription by MDM2: a dual mechanism.

  1997cited by this paper
• Regulation of p53 stability by Mdm2

  1997cited by this paper
• Insulin-like growth factor I stimulates degradation of an mRNA transcript encoding the 14 kDa ubiquitin-conjugating enzyme.

  1996cited by this paper
• Allosteric Regulation of the Thermostability and DNA Binding Activity of Human p53 by Specific Interacting Proteins (*)

  1996cited by this paper
• Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53

  1995cited by this paper
• Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo.

  1995cited by this paper
• Identification of a Family of Closely Related Human Ubiquitin Conjugating Enzymes (*)

  1995cited by this paper
• Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53

  1995cited by this paper
• Adenosine transport in cultured human umbilical vein endothelial cells is reduced in diabetes.

  1994cited by this paper
• A human ubiquitin-conjugating enzyme homologous to yeast UBC8.

  1994cited by this paper
• Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53.

  1994cited by this paper
• Mapping of the p53 and mdm-2 interaction domains.

  1993cited by this paper
• The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

  1992cited by this paper
• Ubiquitin‐conjugating enzymes UBC4 and UBC5 mediate selective degradation of short‐lived and abnormal proteins.

  1990cited by this paper

• Deficiency of psmb6 suppresses proteasome activity and promotes apoptosis in larval zebrafish brain.

  2025cites this paper
• IFN-γ-driven UBE2D3 upregulation impairs antigen presentation pathways and anti-tumor immunity in pancreatic cancer

  2025cites this paper
• MDM2 functions as a timer reporting the length of mitosis

  2025cites this paper
• Molecular Mechanisms of Cadmium-Induced Toxicity and Its Modification

  2025cites this paper
• Elucidating the Role of CNOT2 in Regulating Cancer Cell Growth via the Modulation of p53 and c-Myc Expression

  2025cites this paper
• Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities

  2025cites this paper
• Endoplasmic reticulum stress on glioblastoma: Tumor growth promotion and immunosuppression.

  2025cites this paper
• MDM2 acts as a timer reporting the length of mitosis

  2024cites this paper
• BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism

  2024cites this paper
• High-grade serous carcinoma of the fallopian tube in a young woman with chromosomal 4q abnormality: A case report

  2024cites this paper
• Isoform alterations in the ubiquitination machinery impacting gastrointestinal malignancies

  2024cites this paper
• The Molecular Mechanisms of Cuproptosis and Small-Molecule Drug Design in Diabetes Mellitus

  2024cites this paper
• IGF2BP2-modified UBE2D1 interacts with Smad2/3 to promote the progression of breast cancer.

  2023cites this paper
• Analysis of the interaction of UBE2Q1 with B4GALT1 and P53: Experimental and molecular modeling study.

  2023cites this paper
• A heterozygous mutation in UBE2H in a patient with developmental delay leads to an aberrant brain development in zebrafish

  2023cites this paper
• IRE1 endoribonuclease signaling promotes myeloid cell infiltration in glioblastoma.

  2023cites this paper
• Ubiquitin‑conjugating enzymes as potential biomarkers and therapeutic targets for digestive system cancers (Review)

  2023cites this paper
• Ubiquitinome Profiling Reveals in Vivo UBE2D3 Targets and Implicates UBE2D3 in Protein Quality Control

  2023cites this paper
• Validation of human telomere length trans-ancestry meta-analysis association signals identifies POP5 and KBTBD6 as novel human telomere length regulation genes

  2023cites this paper
• The crosstalk between ubiquitin-conjugating enzyme E2Q1 and p53 in colorectal cancer: An in vitro analysis

  2023cites this paper
• MDM2 E3 ligase activity is essential for p53 regulation and cell cycle integrity

  2022cites this paper
• Ubiquitin receptors play redundant roles in the proteasomal degradation of the p53 repressor MDM2

  2022cites this paper
• The UBE2D ubiquitin conjugating enzymes: Potential regulatory hubs in development, disease and evolution

  2022cites this paper
• E2-E3 ubiquitin enzyme pairing - partnership in provoking or mitigating cancers.

  2022cites this paper
• Identification of Radiation-Induced miRNA Biomarkers Using the CGL1 Cell Model System

  2022cites this paper
• Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q

  2022cites this paper
• Silencing of UBE2D1 inhibited cell migration in gastric cancer, decreasing ubiquitination of SMAD4

  2021cites this paper
• The Molecular Basis of Ubiquitin-Conjugating Enzymes (E2s) as a Potential Target for Cancer Therapy

  2021influential citation
• Targeting ubiquitin conjugating enzyme UbcH5b by a triterpenoid PC3-15 from Schisandra plants sensitizes triple-negative breast cancer cells to lapatinib.

  2021cites this paper
• Dysregulations of Expression of Genes of the Ubiquitin/SUMO Pathways in an In Vitro Model of Amyotrophic Lateral Sclerosis Combining Oxidative Stress and SOD1 Gene Mutation

  2021cites this paper
• Nutrient copper signaling promotes protein turnover by allosteric activation of ubiquitin E2D conjugases

  2021cites this paper
• Exploration of Alternative Splicing (AS) Events in MDV-Infected Chicken Spleens

  2021cites this paper
• UBCH5 Family Members Differentially Impact Stabilization of Mutant p53 via RNF128 Iso1 During Barrett’s Progression to Esophageal Adenocarcinoma

  2021influential citation
• New insight into the role of MDMX in MDM2-mediated p53 degradation and anti-cancer drug development

  2021cites this paper
• Ubiquitin-Conjugating Enzymes in Cancer

  2021cites this paper
• The E2 ubiquitin-conjugating enzyme UbcH5c: an emerging target in cancer and immune disorders.

  2020cites this paper
• Mdm2 enhances ligase activity of parkin and facilitates mitophagy

  2020cites this paper
• Overexpression of ubiquitin-conjugating enzyme E2 L3 in hepatocellular carcinoma potentiates apoptosis evasion by inhibiting the GSK3β/p65 pathway.

  2020cites this paper
• MDMX Recruits UbcH5c to Facilitate MDM2 E3 Ligase Activity and Subsequent p53 Degradation In Vivo

  2020cites this paper
• Novel IRE1-dependent proinflammatory signaling controls tumor infiltration by myeloid cells.

  2020cites this paper
• IRE1-UBE2D3 signaling controls the recruitment of myeloid cells to glioblastoma

  2019cites this paper
• Regulation of signal transduction in Coilia nasus during migration.

  2019cites this paper
• Evolution of an Amniote-Specific Mechanism for Modulating Ubiquitin Signaling via Phosphoregulation of the E2 Enzyme UBE2D3

  2019cites this paper
• Candidate genes mediated by estrogen‐related receptor γ in pancreatic β cells

  2019cites this paper
• LncRNAs-directed PTEN enzymatic switch governs epithelial–mesenchymal transition

  2019cites this paper
• Competitive ubiquitination activates the tumor suppressor p53

  2019cites this paper
• Integrated epigenomic profiling reveals endogenous retrovirus reactivation in renal cell carcinoma

  2019cites this paper
• E2 ubiquitin-conjugating enzymes in cancer: Implications for immunotherapeutic interventions.

  2019cites this paper
• UBE2D1 RNA Expression Was an Independent Unfavorable Prognostic Indicator in Lung Adenocarcinoma, but Not in Lung Squamous Cell Carcinoma

  2018cites this paper
• Gain of UBE2D1 facilitates hepatocellular carcinoma progression and is associated with DNA damage caused by continuous IL-6

  2018cites this paper
• Caenorhabditis elegans un modèle d’étude des différents compartiments du noyau : de l’étude d’un stress du nucléole par inhibition de la voie de neddylation à la mesure de la compaction de la chromatine in vivo

  2018cites this paper
• Top-Down Analysis of Branched Proteins Using Mass Spectrometry.

  2018cites this paper
• Anatomy of Mdm2 and Mdm4 in evolution

  2017cites this paper
• The peroxisomal matrix protein import machinery - a PEX5 - centered perspective

  2017influential citation
• ATP-driven processes of peroxisomal matrix protein import

  2017cites this paper
• Ubiquitination and SUMOylation in Telomere Maintenance and Dysfunction

  2017cites this paper
• Regulation of peroxisomal matrix protein import by ubiquitination.

  2016cites this paper
• Downregulation of Ubiquitin-conjugating Enzyme UBE2D3 Promotes Telomere Maintenance and Radioresistance of Eca-109 Human Esophageal Carcinoma Cells

  2016cites this paper
• The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway

  2016cites this paper
• Accumulation of p53 via down-regulation of UBE2D family genes is a critical pathway for cadmium-induced renal toxicity

  2016cites this paper
• Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.

  2016cites this paper
• Different Regulation of p53 Expression by Cadmium Exposure in Kidney, Liver, Intestine, Vasculature, and Brain Astrocytes

  2016influential citation
• Regulation of the Abundance of Kaposi’s Sarcoma-Associated Herpesvirus ORF50 Protein by Oncoprotein MDM2

  2016cites this paper
• UBE2Q1 in a Human Breast Carcinoma Cell Line: Overexpression and Interaction with p53.

  2015cites this paper
• Phosphomimetic mutation of the N-terminal lid of MDM2 enhances the polyubiquitination of p53 through stimulation of E2-ubiquitin thioester hydrolysis.

  2015cites this paper
• Novel structurally similar chromene derivatives with opposing effects on p53 and apoptosis mechanisms in colorectal HCT116 cancer cells.

  2015cites this paper
• A Co-Module Regulated by Therapeutic Drugs in a Molecular Subnetwork of Alzheimer's Disease Identified on the Basis of Traditional Chinese Medicine and SAMP8 Mice.

  2015cites this paper
• In vitro investigation of the ubiquitination and degradation of p53 by Murine Double Minute 2 (MDM2) and Retinoblastoma Binding Protein 6 (RBBP6)

  2015cites this paper
• The NEDD 8 inhibitor MLN 4924 increases the size of the nucleolus and activates p 53 through the ribosomal-Mdm 2 pathway

  2015cites this paper
• Autoactivation of the MDM2 E3 Ligase by Intramolecular Interaction

  2014cites this paper
• The peroxisomal receptor dislocation pathway: to the exportomer and beyond.

  2014cites this paper
• Limiting the power of p 53 through the ubiquitin proteasome pathway

  2014cites this paper
• Characterization of Functional Domains of Cul3, an E3 Ubiquitin Ligase, Using Chimeric Analysis

  2014cites this paper
• Limiting the power of p53 through the ubiquitin proteasome pathway

  2014cites this paper
• The Peroxisomal Exportomer

  2014cites this paper
• Factors Involved in Ubiquitination and Deubiquitination of PEX5, the Peroxisomal Shuttling Receptor

  2014cites this paper
• FATS is an E2-independent ubiquitin ligase that stabilizes p53 and promotes its activation in response to DNA damage

  2014cites this paper
• Mechanisms of hexabromocyclododecanes induced developmental toxicity in marine medaka (Oryzias melastigma) embryos.

  2014cites this paper
• Award Number: W81XWH-11-1-0697 TITLE: Enhancement of the efficacy of conventional anticancer compounds through the repression of SNAI proteins in aggressive breast cancer cells

  2014cites this paper
• Ubiquitination involved enzymes and cancer

  2014cites this paper
• Ubiquitin in the peroxisomal protein import pathway.

  2014cites this paper
• Inorganic arsenic induces apoptosis through downregulation of Ube2d genes and p53 accumulation in rat proximal tubular cells.

  2013cites this paper
• Gene expression modifications in Wharton’s Jelly mesenchymal stem cells promoted by prolonged in vitro culturing

  2013cites this paper
• Inhibition of UBE2D3 Expression Attenuates Radiosensitivity of MCF-7 Human Breast Cancer Cells by Increasing hTERT Expression and Activity

  2013cites this paper
• Microarray characterization of gene expression changes in blood during acute ethanol exposure

  2013cites this paper
• Hip2 ubiquitin-conjugating enzyme overcomes radiation-induced G2/M arrest.

  2013cites this paper
• Auto-ubiquitination of Mdm2 Enhances Its Substrate Ubiquitin Ligase Activity*

  2013cites this paper
• The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a

  2013cites this paper
• Comprehensive Ubiquitin E2 Profiling of Ten Ubiquitin E3 Ligases

  2013influential citation
• The deubiquitinating enzyme USP 2 a regulates the p 53 pathway by targeting Mdm 2

  2013cites this paper
• The exportomer: the peroxisomal receptor export machinery

  2013cites this paper
• MDM2, MDMX and p53 in oncogenesis and cancer therapy

  2013cites this paper
• A comprehensive framework of E 2 – RING E 3 interactions of the human ubiquitin – proteasome system

  2013cites this paper
• Control of the tumor suppressor p53 by regulating Mdm2 activity and stability

  2013cites this paper
• Characterization of the Roles of TopoIIIα-RMI1 in Maintaining Genome Integrity

  2013cites this paper
• Regulation of p53: a collaboration between Mdm2 and MdmX

  2012cites this paper
• Ubiquitin- and ubiquitin-like proteins-conjugating enzymes (E2s) in breast cancer

  2012cites this paper
• Genome-wide profiling of methylation identifies novel targets with aberrant hyper-methylation and reduced expression in low-risk myelodysplastic syndromes

  2012cites this paper
• [Cadmium induces p53-dependent apoptosis through the inhibition of Ube2d family gene expression].

  2012cites this paper
• Characterization of N-terminal Myc Ubiquitylation and the Novel Oncogene CUL7

  2012influential citation